LIPOPROTEIN METABOLISM
- Exogenous pathway: chylomicrons clear dietary lipids
- Endogenous pathway: VLDL and LDL transport/distribute endogenously synthesized lipids
- Reverse cholesterol transport: HDL clears excess plasma cholesterol
Enzymes
- Degrade triacylglycerol to glycerol and free fatty acids
- Lipoprotein lipase (LPL), bound to the endothelial layer of peripheral capillaries.
- Hepatic lipase, localizes within hepatic endothelial cells.
HIGH DENSITY LIPOPROTEIN (HDL)
- “Good cholesterol”
- Transports second most cholesterol (first LDL)
- Reservoir for lipoproteins
REVERSE CHOLESTEROL TRANSPORT
Step 1: Liver and small intestine synthesize nascent HDL
- Disc shape with ApoA-I and ApoA-II
- Heterogeneity exists: nascent HDL may have ApoA-I only, ApoA-II only or both
Step 2: Nascent HDL picks up free cholesterol from peripheral tissues to become HDL3
Step 3: Nascent HDL picks up LCAT from plasma as it becomes HDL3
Lecithin acyl transferase (LCAT) esterifies free cholesterol
HDL3
- Circular HDL particle with CE (esterifies free cholesterol with LCAT)
- Apolipoproteins on surface: ApoA-I, ApoA-II, ApoE & ApoC-II
- Circulating lipoproteins donate ApoE and ApoC-II to HDL3
Step 4: HDL3 picks up more free cholesterol to become HDL2
HDL2
- Larger HDL particle with more CE (same lipoproteins as HDL3)
- Contains cholesterol ester transfer protein
Cholesterol ester transfer protein (CETP) transfers lipids between HDL and VLDL
- Activated by ApoA-II
Step 5: CETP transfers CE (from HDL) to VLDL, and TAG (from VLDL) to HDL - Endogenous pathway: VLDL eventually degrades to LDL (redistributes cholesterol)
Step 6: HDL2 binds scavenger receptor (SR-B1) on liver - HDL2 continues accumulating plasma cholesterol before binding
- Hepatic lipases degrade TAG & membrane phospholipids: HDL2 –> HDL3
- Liver converts excess cholesterol to bile salts (digestive elimination)
CLINICAL CORRELATION
Corneal clouding
- Symptom of LCAT or ApoA-I deficiency
- HDL cannot esterify cholesterol
- Leads to rapid HDL degradation: excess cholesterol deposits in cornea and peripheral vessels
